Maxim Kuzin

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Major Depressive Disorder

Respiratory Syndrome Coronavirus

Top Venues

Therapeutic drug monitoring

Basic & clinical pharmacology & toxicology

International journal of psychiatry in clinical practice

Journal of psychopharmacology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic drug monitoring (2024)
Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic drug monitoring (2024)
Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic drug monitoring 46 (2) (2024)
Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic drug monitoring (2024)
Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic drug monitoring 46 (2) (2024)
Maxim Kuzin, Fabian Gardin, Markus Götschi, Franziskos Xepapadakos, Wolfram Kawohl, Erich Seifritz, Antje Trauzeddel, Michael Paulzen, Georgios Schoretsanitis
Changes in Psychotropic Drug Blood Levels After SARS-CoV-2 Vaccination: A Two-Center Cohort Study. Therapeutic drug monitoring (2023)
Pierre Baumann, Philipp Bauknecht, Maxim Kuzin, Georgios Schoretsanitis
Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review. International journal of psychiatry in clinical practice (2023)
Maxim Kuzin, Georgios Schoretsanitis, Fabian Gardin, Götschi Markus, Wolfram Kawohl, Franziskos Xepapadakos
Switching From Aripiprazole Tablets to Oral Suspension in a Patient With Roux-en-Y Gastric Bypass: A Case Report. Journal of clinical psychopharmacology (2023)
Maxim Kuzin, Ekkehard Haen, Christoph Hiemke, Benjamin Bochon, Karolina Bochon, Gerhard Gründer, Michael Paulzen, Georgios Schoretsanitis
Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis. Journal of psychopharmacology (Oxford, England) 35 (3) (2021)
Maxim Kuzin, Franziskos Xepapadakos, Isabel Scharrer, Marc Augsburger, Chin Bin Eap, Georgios Schoretsanitis
The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report. Basic & clinical pharmacology & toxicology 129 (1) (2021)
Maxim Kuzin, Georgios Schoretsanitis, Ekkehard Haen, Florian Ridders, Christoph Hiemke, Gerhard Gründer, Michael Paulzen
Pharmacokinetic interactions between clozapine and sertraline in smokers and non-smokers. Basic & clinical pharmacology & toxicology 127 (4) (2020)
Maxim Kuzin, Isabel Scharrer, Daniele Nolan, Markus Baumgartner, Michael Paulzen, Georgios Schoretsanitis, Franziskos Xepapadakos
The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report. Basic & clinical pharmacology & toxicology 127 (4) (2020)